Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma.
Legros L, Pascale A, Guettier C, Eftekhari P, Merabet YB, Stang M, Bossevot R, Goldschmidt E, Ulusakarya A, Morisset S, Lewin M, Samuel D, Rosmorduc O. Legros L, et al. Among authors: goldschmidt e. Cancer Chemother Pharmacol. 2023 Apr;91(4):337-344. doi: 10.1007/s00280-023-04519-6. Epub 2023 Mar 24. Cancer Chemother Pharmacol. 2023. PMID: 36961524 Free PMC article.
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.
Machover D, Delmas-Marsalet B, Misra SC, Gumus Y, Goldschmidt E, Schilf A, Frénoy N, Emile JF, Debuire B, Guettier C, Farrokhi P, Boulefdaoui B, Norol F, Parquet N, Ulusakarya A, Jasmin C. Machover D, et al. Among authors: goldschmidt e. Ann Oncol. 2001 Oct;12(10):1439-43. doi: 10.1023/a:1012501305214. Ann Oncol. 2001. PMID: 11762817 Free article. Clinical Trial.
Symptoms in cancer patients and an unusual tumor: Case 1. Regression of hypertrophic pulmonary osteoarthropathy following chemotherapy for lung metastases of a nasopharyngeal carcinoma.
Ulusakarya A, Gumus Y, Brahimi N, Delmas-Marsalet B, Almohamad W, Misra SC, Goldschmidt E, Haydar M, Machover D. Ulusakarya A, et al. Among authors: goldschmidt e. J Clin Oncol. 2005 Dec 20;23(36):9422-3. doi: 10.1200/JCO.2004.00.8474. J Clin Oncol. 2005. PMID: 16361641 No abstract available.
Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.
Machover D, Delmas-Marsalet B, Misra SC, Ulusakarya A, Gumus Y, Frénoy N, Guettier C, Saffroy R, Innominato P, Almohamad W, Brahimi N, Haydar M, Goldschmidt E. Machover D, et al. Among authors: goldschmidt e. Biomed Pharmacother. 2010 Feb;64(2):83-7. doi: 10.1016/j.biopha.2009.11.001. Epub 2009 Dec 9. Biomed Pharmacother. 2010. PMID: 20044233 Clinical Trial.
336 results